A First in Human Study to Evaluate Safety, Tolerability, Pharmacology of HS-10374 in Healthy Subjects
Clinical trial NCT06033742 · COMPLETED
Trial details
- NCT number
- NCT06033742
- Sponsor
- Jiangsu Hansoh Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-13
- Primary completion
- 2023-03-24
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.